Gastrointestinal Diagnostics Market Gastrointestinal Diagnostics Market Dublin, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The ...

The Neuro-Gastroenterology and Pediatric Motility Center is a nationally recognized institution, one of the few in the country that is dedicated to diagnosing and treating motility disorders and neuro ...

Gvoke VialDx is expected to be available in the third quarter of 2025. The Food and Drug Administration (FDA) has approved Gvoke VialDx ™ (glucagon) for intravenous use as a diagnostic aid during ...

For as long as he can remember, Howard Gitlow, 72, has suffered from debilitating heartburn. Myriad over-the-counter and prescription medications including diagnostic endoscopies never fixed the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Previous reports indicated that in-hospital famotidine ...

Motility disorders are disorders where the gastrointestinal tract has lost its ability to coordinate the muscles that perform common functions, such as swallowing or moving food and waste through the ...

Please provide your email address to receive an email when new articles are posted on . Transit time measurements were consistent between the Atmo Gas Sensing Capsule and Medtronic’s SmartPill. The ...

Understanding how GLP-2 controls appetite could unlock new strategies for combating obesity, offering hope for more effective treatments. Study: The Possible Involvement of Glucagon-like Peptide-2 in ...

The global market for Gastrointestinal Diagnostics was valued at US$4.9 Billion in 2024 and is projected to reach US$5.8 Billion by 2030, growing at a CAGR of 2.8% from 2024 to 2030. This ...